Lantern Pharma (LTRN) Short Interest Ratio & Short Volume → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free LTRN Stock Alerts $5.77 +0.05 (+0.87%) (As of 05:46 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Lantern Pharma Short Interest DataCurrent Short Volume420,900 sharesPrevious Short Volume144,600 sharesChange Vs. Previous Month+191.08%Dollar Volume Sold Short$3.70 millionShort Interest Ratio / Days to Cover1.5Last Record DateMarch 31, 2024Outstanding Shares10,740,000 sharesFloat Size7,890,000 sharesShort Percent of Float5.33%Today's Trading Volume127,435 sharesAverage Trading Volume258,047 sharesToday's Volume Vs. Average49% Short Selling Lantern Pharma ? Sign up to receive the latest short interest report for Lantern Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLTRN Short Interest Over TimeLTRN Days to Cover Over TimeLTRN Percentage of Float Shorted Over Time Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… Lantern Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024420,900 shares $3.70 million +191.1%5.3%1.5 $8.80 3/15/2024144,600 shares $1.26 million +112.7%1.8%0.6 $8.70 2/29/202468,000 shares $327,080.00 +14.1%0.9%0.5 $4.81 2/15/202459,600 shares $238,996.00 -14.2%0.8%1.6 $4.01 1/31/202469,500 shares $293,290.00 -4.3%0.9%1.6 $4.22 1/15/202472,600 shares $295,482.00 +17.1%1.0%1.6 $4.07 Get the Latest News and Ratings for LTRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lantern Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/202362,000 shares $265,360.00 -65.7%0.8%1.4 $4.28 12/15/2023180,500 shares $776,150.00 -20.1%2.4%4.3 $4.30 11/30/2023226,000 shares $892,700.00 +25.0%3.0%5.9 $3.95 11/15/2023180,800 shares $725,008.00 +19.7%2.4%5.1 $4.01 10/31/2023151,000 shares $374,480.00 -2.6%2.0%5.8 $2.48 10/15/2023155,000 shares $509,950.00 +0.1%2.1%5.9 $3.29 9/30/2023154,800 shares $527,868.00 -0.3%2.1%4.9 $3.41 9/15/2023155,200 shares $630,112.00 -3.5%2.1%4.1 $4.06 8/31/2023160,800 shares $726,816.00 +2.9%2.2%3.8 $4.52 8/15/2023156,200 shares $729,454.00 +9.4%2.1%3.6 $4.67 7/31/2023142,800 shares $661,164.00 -2.9%1.9%3.3 $4.63 7/15/2023147,100 shares $728,145.00 +5.2%2.0%3.6 $4.95 6/30/2023139,900 shares $789,036.00 +0.1%1.9%3.9 $5.64 6/15/2023139,800 shares $826,218.00 -0.1%1.9%4.6 $5.91 5/31/2023139,900 shares $728,879.00 -0.9%1.9%4.8 $5.21 5/15/2023141,200 shares $748,360.00 +0.7%1.9%5.2 $5.30 4/30/2023140,200 shares $686,980.00 -2.4%2.1%5.6 $4.90 4/15/2023143,600 shares $722,308.00 -0.4%2.1%5.1 $5.03 3/31/2023144,200 shares $696,486.00 +0.9%2.1%4.7 $4.83 3/15/2023142,900 shares $661,627.00 +0.4%2.1%3.7 $4.63 2/28/2023142,400 shares $781,761.76 -0.8%2.1%3.9 $5.49 2/15/2023143,500 shares $777,770.00 -14.3%2.0%4.1 $5.42 1/31/2023167,400 shares $1.01 million -2.0%2.3%2.9 $6.02 1/15/2023170,800 shares $935,984.00 +15.7%2.3%3 $5.48 12/30/2022147,600 shares $891,504.00 -1.0%2.0%2.6 $6.04 12/15/2022149,100 shares $814,086.00 +2.8%2.0%2.9 $5.46 11/30/2022145,000 shares $725,000.00 -2.1%2.0%3 $5.00 11/15/2022148,100 shares $827,879.00 -3.0%1.8%3.1 $5.59 10/31/2022152,700 shares $639,813.00 -1.0%1.9%3.5 $4.19 10/15/2022154,300 shares $742,183.00 +57.9%2.0%6.3 $4.81 9/30/202297,700 shares $467,006.00 +53.6%1.2%2.5 $4.78 9/15/202263,600 shares $318,636.00 -2.8%0.8%1.7 $5.01 8/31/202265,400 shares $338,118.00 -26.9%0.8%1.8 $5.17 8/15/202289,500 shares $581,750.00 -5.3%1.1%2.4 $6.50top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… LTRN Short Interest - Frequently Asked Questions What is Lantern Pharma's current short interest? Short interest is the volume of Lantern Pharma shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 420,900 shares of LTRN short. 5.33% of Lantern Pharma's shares are currently sold short. Learn More on Lantern Pharma's current short interest. What is a good short interest ratio for Lantern Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LTRN shares currently have a short interest ratio of 2.0. Learn More on Lantern Pharma's short interest ratio. What is a good short interest percentage for Lantern Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.33% of Lantern Pharma's floating shares are currently sold short. Is Lantern Pharma's short interest increasing or decreasing? Lantern Pharma saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 420,900 shares, an increase of 191.1% from the previous total of 144,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lantern Pharma's float size? Lantern Pharma currently has issued a total of 10,740,000 shares. Some of Lantern Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lantern Pharma currently has a public float of 7,890,000 shares. How does Lantern Pharma's short interest compare to its competitors? 5.33% of Lantern Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Lantern Pharma: Equillium, Inc. (6.27%), Kronos Bio, Inc. (1.69%), Marinus Pharmaceuticals, Inc. (6.32%), Landos Biopharma, Inc. (0.17%), Celularity Inc. (3.94%), Immix Biopharma, Inc. (2.81%), Eagle Pharmaceuticals, Inc. (10.59%), Rallybio Co. (7.60%), HCW Biologics Inc. (0.09%), Checkpoint Therapeutics, Inc. (12.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Lantern Pharma stock? Short selling LTRN is an investing strategy that aims to generate trading profit from Lantern Pharma as its price is falling. LTRN shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lantern Pharma? A short squeeze for Lantern Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LTRN, which in turn drives the price of the stock up even further. How often is Lantern Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LTRN, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: EQ Short Squeeze KRON Short Squeeze MRNS Short Squeeze LABP Short Squeeze CELU Short Squeeze IMMX Short Squeeze EGRX Short Squeeze RLYB Short Squeeze HCWB Short Squeeze CKPT Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LTRN) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeHow to camouflage a factory of 53,000 workersStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders